FDA drug recalls

250 U.S. FDA drug recall enforcement reports are indexed here, filed by 86 recalling firms under 118 FDA enforcement events, with report dates running 2026-04-29 to 2026-08-12. They break down as 11 Class I, 213 Class II, 25 Class III and 1 unclassified, and by lifecycle status as 250 ongoing. 31 events cover more than one recall number — 163 records in total — because the FDA issues one recall number per recalled product configuration and one event ID per enforcement action. 204 records print at least one NDC in the product description, 247 state a strength and 136 describe a package size; the median gap between a firm initiating a recall and the FDA publishing it is 23 days. 38 products are named by more than one record. This hub is a finding aid for locating and dating official recall records: regulatory information only, and not medical advice.

250 Recalls indexed
11 Class I
213 Class II
2026-08-22 Last updated

What the indexed enforcement stream contains

Recall records 250
FDA enforcement events 118 (31 covering more than one recall number)
Recalling firms 86 (39 with more than one record)
Distinct products named 157 (38 named by more than one record)
Report date range 2026-04-29 → 2026-08-12
Recall initiation range 2025-12-27 → 2026-08-05
Median report lag 23 days from initiation to FDA report
Country of record United States (213) · India (27) · Vietnam (8) · Taiwan (2)
Distribution scope nationwide-us (240) · regional (8) · other (2)
Product forms (top) Tablets (48) · Solution (30) · Injection (24) · Chewable Tablets (17) · Gel (15) · Eye Drops (12) · Capsules (10) · for Injection (10)
Marketing category Rx only (116)
Records with an NDC / UPC 204 NDC · 37 UPC
Records with a termination date 0

Recall classification: Class I, Class II and Class III

The FDA assigns each recall a classification expressing the agency's regulatory assessment of the recall event. These are administrative tiers, not scores of how dangerous a product is to any specific person, and they cannot be translated into personal risk. In the indexed dataset:

Each tier page carries that tier's own firm index, its multi-record enforcement events, its recurring products and its report-month distribution, alongside the complete record listing. For the precise definitions of every field and tier used across these pages see the regulatory intelligence glossary, and for the data lineage the methodology and FDA data sources pages.

Recall status in the indexed data

Each enforcement report carries a status describing where the recall sits in its lifecycle. Across the 250 indexed records the breakdown is 250 ongoing , and no record yet carries a termination date. A status of "terminated" means the FDA has recorded the recall as concluded; "ongoing" means the action was still in progress when the report was published. Because the ingested window is recent, a single status can dominate — the live value should always be confirmed against the official source.

Enforcement events covering more than one recall number

One FDA event ID is one enforcement action; one recall number is one recalled product configuration. These 31 events each cover several recall numbers — usually different strengths, package sizes or NDCs of the same action. Each record keeps its own page because each has its own recall number, classification and dates.

Event IDRecordsRecalling firmRecall numbers
99098 23 Guardian Drug Co. Inc. D-0557-2026 · D-0558-2026 · D-0559-2026 · D-0560-2026 · D-0561-2026 · D-0562-2026 · +17 more on each record page
99137 14 Dabur India Ltd D-0629-2026 · D-0630-2026 · D-0631-2026 · D-0632-2026 · D-0633-2026 · D-0634-2026 · +8 more on each record page
99399 12 Major Pharmaceuticals D-0700-2026 · D-0701-2026 · D-0702-2026 · D-0703-2026 · D-0704-2026 · D-0705-2026 · +6 more on each record page
99278 11 Bell Pharmaceuticals, Inc D-0678-2026 · D-0679-2026 · D-0680-2026 · D-0681-2026 · D-0682-2026 · D-0683-2026 · +5 more on each record page
99217 10 Carefusion 213, LLC D-0643-2026 · D-0644-2026 · D-0645-2026 · D-0646-2026 · D-0647-2026 · D-0648-2026 · +4 more on each record page
98731 8 Blaine Labs Inc D-0692-2026 · D-0693-2026 · D-0694-2026 · D-0695-2026 · D-0696-2026 · D-0697-2026 · +2 more on each record page
99440 8 Rohto-mentholatum (vietnam) Co., Ltd. D-0715-2026 · D-0716-2026 · D-0717-2026 · D-0718-2026 · D-0719-2026 · D-0720-2026 · +2 more on each record page
98694 7 Wells Pharma OF Houston LLC D-0502-2026 · D-0503-2026 · D-0504-2026 · D-0505-2026 · D-0506-2026 · D-0507-2026 · +1 more on each record page
99076 7 Keystone Industries D-0600-2026 · D-0601-2026 · D-0602-2026 · D-0603-2026 · D-0604-2026 · D-0605-2026 · +1 more on each record page
99138 6 Gasco Industrial Corp. D-0665-2026 · D-0666-2026 · D-0667-2026 · D-0668-2026 · D-0669-2026 · D-0670-2026
99077 5 Amgen, Inc. D-0612-2026 · D-0613-2026 · D-0614-2026 · D-0615-2026 · D-0616-2026
99449 5 Fresenius Kabi Usa, LLC D-0725-2026 · D-0726-2026 · D-0727-2026 · D-0728-2026 · D-0729-2026
99000 4 Pai Holdings LLC D-0589-2026 · D-0590-2026 · D-0591-2026 · D-0592-2026
99114 4 Carefusion 213, LLC D-0622-2026 · D-0623-2026 · D-0624-2026 · D-0625-2026
99312 4 Reliance Life Sciences Private Ltd D-0671-2026 · D-0672-2026 · D-0673-2026 · D-0674-2026
98785 3 Ajanta Pharma Ltd. D-0514-2026 · D-0515-2026 · D-0516-2026
99350 3 Cipla Usa, Inc. D-0661-2026 · D-0675-2026 · D-0676-2026
99421 3 Ascend Laboratories, LLC D-0737-2026 · D-0738-2026 · D-0739-2026
98693 2 B Braun Medical Inc D-0496-2026 · D-0498-2026
98790 2 Carefusion 213, LLC D-0517-2026 · D-0518-2026

Firms with more than one indexed recall

39 of the 86 recalling firms in the indexed data appear on more than one enforcement report. Each links to the firm's regulatory profile, which aggregates its recall and shortage records across the indexed datasets. These counts are coverage-limited activity signals over the ingested window — they are not quality ratings and carry no judgement about a company.

Recalling firmRecordsFDA eventsRecall records
Guardian Drug Co. Inc. 23 1 D-0557-2026 · D-0558-2026 · D-0559-2026 · D-0560-2026 · D-0561-2026 · +18 more
Carefusion 213, LLC 17 4 D-0690-2026 · D-0643-2026 · D-0644-2026 · D-0645-2026 · D-0646-2026 · +12 more
Dabur India Ltd 14 1 D-0629-2026 · D-0630-2026 · D-0631-2026 · D-0632-2026 · D-0633-2026 · +9 more
Major Pharmaceuticals 12 1 D-0700-2026 · D-0701-2026 · D-0702-2026 · D-0703-2026 · D-0704-2026 · +7 more
Bell Pharmaceuticals, Inc 11 1 D-0678-2026 · D-0679-2026 · D-0680-2026 · D-0681-2026 · D-0682-2026 · +6 more
Ascend Laboratories, LLC 9 6 D-0737-2026 · D-0738-2026 · D-0739-2026 · D-0712-2026 · D-0735-2026 · +4 more
Blaine Labs Inc 8 1 D-0692-2026 · D-0693-2026 · D-0694-2026 · D-0695-2026 · D-0696-2026 · +3 more
Rohto-mentholatum (vietnam) Co., Ltd. 8 1 D-0715-2026 · D-0716-2026 · D-0717-2026 · D-0718-2026 · D-0719-2026 · +3 more
Keystone Industries 7 1 D-0600-2026 · D-0601-2026 · D-0602-2026 · D-0603-2026 · D-0604-2026 · +2 more
Wells Pharma OF Houston LLC 7 1 D-0502-2026 · D-0503-2026 · D-0504-2026 · D-0505-2026 · D-0506-2026 · +2 more
Fresenius Kabi Usa, LLC 6 2 D-0725-2026 · D-0726-2026 · D-0727-2026 · D-0728-2026 · D-0729-2026 · +1 more
Gasco Industrial Corp. 6 1 D-0665-2026 · D-0666-2026 · D-0667-2026 · D-0668-2026 · D-0669-2026 · +1 more
Sun Pharmaceutical Industries Inc 6 5 D-0654-2026 · D-0628-2026 · D-0580-2026 · D-0607-2026 · D-0598-2026 · +1 more
Amgen, Inc. 5 1 D-0612-2026 · D-0613-2026 · D-0614-2026 · D-0615-2026 · D-0616-2026
Asclemed Usa Inc. 4 3 D-0713-2026 · D-0658-2026 · D-0659-2026 · D-0555-2026
Pai Holdings LLC 4 1 D-0589-2026 · D-0590-2026 · D-0591-2026 · D-0592-2026
Reliance Life Sciences Private Ltd 4 1 D-0671-2026 · D-0672-2026 · D-0673-2026 · D-0674-2026
Ajanta Pharma Ltd. 3 1 D-0514-2026 · D-0515-2026 · D-0516-2026
B Braun Medical Inc 3 2 D-0540-2026 · D-0496-2026 · D-0498-2026
Breckenridge Pharmaceutical, Inc. 3 2 D-0582-2026 · D-0583-2026 · D-0522-2026

Products named by more than one recall record

Matched on the product-name prefix of the FDA's own product description, so different strengths and package sizes of the same product group together. 38 products in the indexed data are named by more than one record.

ProductRecordsFirmsRecall records
Levothyroxine Sodium 13 2 D-0700-2026 · D-0701-2026 · D-0702-2026 · D-0703-2026 · D-0704-2026 · +8 more
Med Pride 8 1 D-0635-2026 · D-0636-2026 · D-0637-2026 · D-0638-2026 · D-0639-2026 · +3 more
Rohto Cooling 8 1 D-0715-2026 · D-0716-2026 · D-0717-2026 · D-0718-2026 · D-0719-2026 · +3 more
BD ChloraPrep Clear 6 1 D-0690-2026 · D-0645-2026 · D-0651-2026 · D-0652-2026 · D-0622-2026 · +1 more
Duloxetine 6 2 D-0582-2026 · D-0583-2026 · D-0514-2026 · D-0515-2026 · D-0516-2026 · +1 more
Primidone 6 4 D-0585-2026 · D-0533-2026 · D-0534-2026 · D-0535-2026 · D-0536-2026 · +1 more
Dabigatran Etexilate 5 1 D-0737-2026 · D-0738-2026 · D-0739-2026 · D-0735-2026 · D-0736-2026
fentaNYL Citrate Injectable 5 1 D-0503-2026 · D-0504-2026 · D-0505-2026 · D-0506-2026 · D-0508-2026
Lidocaine HCl 4 4 D-0726-2026 · D-0659-2026 · D-0552-2026 · D-0554-2026
VistaPharm 4 1 D-0589-2026 · D-0590-2026 · D-0591-2026 · D-0592-2026
BD ChloraPrep Hi-Lite Orange 3 1 D-0643-2026 · D-0647-2026 · D-0648-2026
BD PurPrep 3 1 D-0644-2026 · D-0517-2026 · D-0518-2026
CAREone 3 2 D-0688-2026 · D-0565-2026 · D-0566-2026
Cinacalcet Hydrochloride 3 1 D-0661-2026 · D-0675-2026 · D-0676-2026
Drogueria San Juan Puerto Rico Isopropyl Alcohol 3 1 D-0668-2026 · D-0669-2026 · D-0670-2026
FAMILY Wellness 3 2 D-0683-2026 · D-0568-2026 · D-0569-2026

Enforcement reports by month

Report-date months across the indexed data. The report date is when the FDA published the enforcement report, normally later than the date the firm began the recall — a median of 23 days later in this dataset.

Report monthRecordsEventsFirms
2026-081188
2026-071114438
2026-06742825
2026-05483332
2026-04655

Latest enforcement reports

The 25 most recent enforcement reports in the indexed dataset, newest first by report date. Each links to its own record page and, from there, to the verifiable openFDA source.

RecordTypeDate
Dicyclomine Hydrochloride CapsulesClass II · Aurobindo Pharma Usa Inc2026-08-12
Total Parental Nutrition - Pediatric PN Patient-Specific TPN BagClass III · Central Admixture Pharmacy Services Inc2026-08-12
Cyclophosphamide for InjectionClass I · Sunny Pharmtech Inc.2026-08-12
Cyclophosphamide for InjectionClass I · Sunny Pharmtech Inc.2026-08-12
Mirabegron Extended-Release TabletsClass II · Zydus Pharmaceuticals (usa) Inc2026-08-12
Dorzolamide HCl and Timolol Maleate Ophthalmic SolutionClass II · Micro Labs Usa Inc2026-08-05
Azelaic Acid GelClass II · Glenmark Pharmaceuticals Inc., Usa2026-08-05
Mycophenolate Mofetil for Injection USPClass II · Mylan Pharmaceuticals Inc2026-08-05
Dabigatran Etexilate CapsulesClass III · Ascend Laboratories, LLC2026-08-05
Dabigatran Etexilate CapsulesClass III · Ascend Laboratories, LLC2026-08-05
Dabigatran Etexilate CapsulesClass III · Ascend Laboratories, LLC2026-08-05
Levothyroxine Sodium TabletsClass II · Major Pharmaceuticals2026-07-29
Levothyroxine Sodium TabletsClass II · Major Pharmaceuticals2026-07-29
Levothyroxine Sodium TabletsClass II · Major Pharmaceuticals2026-07-29
Levothyroxine Sodium TabletsClass II · Major Pharmaceuticals2026-07-29
Levothyroxine Sodium TabletsClass II · Major Pharmaceuticals2026-07-29
Levothyroxine Sodium TabletsClass II · Major Pharmaceuticals2026-07-29
Levothyroxine Sodium TabletsClass II · Major Pharmaceuticals2026-07-29
Levothyroxine Sodium TabletsClass II · Major Pharmaceuticals2026-07-29
Levothyroxine Sodium TabletsClass II · Major Pharmaceuticals2026-07-29
Levothyroxine Sodium TabletsClass II · Major Pharmaceuticals2026-07-29
Levothyroxine Sodium TabletsClass II · Major Pharmaceuticals2026-07-29
Levothyroxine Sodium TabletsClass II · Major Pharmaceuticals2026-07-29
Amlodipine and Olmesartan Medoxomil TabletsClass II · Ascend Laboratories, LLC2026-07-29
Lidolog KitClass III · Asclemed Usa Inc.2026-07-29

Records without a classification (1)

Enforcement reports the source publishes without a classification. They are listed here because the Class I, II and III indexes cannot cover them, and every record must remain reachable from an index page.

RecordTypeDate
Trokendi XRSupernus Pharmaceuticals, Inc.2026-07-29

Records with no shared event, firm or product (40)

These records are the only recall from their firm, the only one naming their product, and the only recall number under their event ID. Nothing in the relation graph links them strongly, so the hub links them directly rather than leaving them to the weakest relation buckets.

Recall recordRecall numberFDA tierRecalling firmReported
Dicyclomine Hydrochloride Capsules, 10mg D-0733-2026 Class II Aurobindo Pharma Usa Inc 2026-08-12
Dorzolamide HCl and Timolol Maleate Ophthalmic Solution, 2%/0.5% D-0730-2026 Class II Micro Labs Usa Inc 2026-08-05
Mycophenolate Mofetil for Injection USP, 500 mg/Vial D-0734-2026 Class II Mylan Pharmaceuticals Inc 2026-08-05
Rising, 2mg/5 mL D-0724-2026 Class II Rising Pharma Holding, Inc. 2026-07-29
Divalproex Sodium Delayed-Release Tablets, 500 mg D-0742-2026 Class II Bionpharma Inc. 2026-07-29
Trokendi XR, 25mg Unclassified Supernus Pharmaceuticals, Inc. 2026-07-29
Nystatin Cream USP, 15 g D-0677-2026 Class II Padagis US LLC 2026-07-22
CLEVIPREX (clevidipine injectable emulsion) 50 mg/100 mL (0.5 mg/mL) D-0689-2026 Class II Chiesi Usa, Inc. 2026-07-22
Medline Remedy Specialized Silicone Cream (Hydraguard-D ), 59 mL D-0663-2026 Class II Biomed Laboratories, Llc. 2026-07-15
Clomiphene Citrate USP Active Pharmaceutical Ingredient (CAS : 50-41-9), 1 KG D-0691-2026 Class II Shimoga Chemicals 2026-07-15
IMULDOSA, 130 mg/26 mL D-0653-2026 Class II Accord Biopharma Inc 2026-07-08
Synjardy XR Tablets, 1000 mg D-0657-2026 Class II Boehringer Ingelheim Pharmaceuticals, Inc. 2026-07-08
Gemcitabine Injection, 1 g D-0714-2026 Class II Mckesson 2026-07-08
DULOXETINE D/R, 30 mg D-0617-2026 Class II Direct RX 2026-07-01
PReye Vitamin See Antioxidant Preservative Free Eye Drops D-0621-2026 Class II Preye LLC 2026-07-01
Lacosamide Tablets, 100mg D-0626-2026 Class II Annora Pharma Private Ltd 2026-07-01
Povi-One, 10% D-0627-2026 Class II Elevate Oral Care 2026-07-01
Buprenorphine HCl, 0.3 mg/mL D-0596-2026 Class II Par Health Usa, LLC 2026-06-24
Focalin XR (dexmethylphenidate HCl) 5 mg D-0608-2026 Class III Sandoz Inc 2026-06-24
Chlorthalidone Tablets, 25 mg D-0610-2026 Class II Inventia Healthcare Ltd 2026-06-24
Zep, 70% D-0586-2026 Class II Zep Inc 2026-06-17
BEEKEEPER'S NATURALS Saline Nasal Spray, 30 mL D-0620-2026 Class I Beekeeper's Naturals Usa Inc. 2026-06-17
Nicotine Transdermal System Patch, 14 mg D-0550-2026 Class III Aveva Drug Delivery Systems, Inc. 2026-06-03
PRED MILD, 0.12% D-0551-2026 Class III Abbvie Inc. 2026-06-03
Busulfan Injection, 60 mg D-0539-2026 Class III Sagent Pharmaceuticals 2026-05-27
cimzia (certolizumab pegol) D-0546-2026 Class II Ucb Biosciences Inc. 2026-05-27
MG217 Multi-Symptom Treatment Cream & Skin Protectant (colloidal oatmeal 2%) D-0553-2026 Class I Wisconsin Pharmacal Company 2026-05-27
Oasis Tears PF, 10mL D-0525-2026 Class II Oasis Medical, Inc. 2026-05-20
Buprenorphine Hydrochloride, 0.3mg/mL D-0527-2026 Class II Endo Usa, Inc. 2026-05-20
busPIRone Hydrochloride Tablets, 5 mg D-0511-2026 Class III Unichem Pharmaceuticals Usa Inc. 2026-05-13
Octreotide Acetate for Injectable Suspension, 30 mg D-0519-2026 Class II Teva Pharmaceuticals Usa, Inc 2026-05-13
NAPROXEN ORAL SUSPENSION, 125 mg/5mL D-0523-2026 Class II Acella Pharmaceuticals, LLC 2026-05-13
TPN bag (patient specific), 1660 mL D-0524-2026 Class II Central Admixture Pharmacy Services, Inc (caps) Los Angeles 2026-05-13
Levocarnitine Injection, 1 g/5 mL D-0494-2026 Class III American Regent, Inc. 2026-05-06
Optase Dry Eye Intense Drops (Glycerin 0.2%) D-0499-2026 Class II Scope Health 2026-05-06
Lidocaine Wound Gel, 0.13% D-0509-2026 Class III Water-jel Technologies, LLC 2026-05-06
Alendronate Sodium Oral Solution, 70 mg/75 mL D-0526-2026 Class II Hikma Pharmaceuticals Usa Inc 2026-05-06
Furosemide Tablets, 80 mg D-0486-2026 Class II Leading Pharma, LLC 2026-04-29
FRESHKOTE LUBRICANT EYEDROPS, 10mL D-0489-2026 Class II Harrow Eye LLC 2026-04-29
Premier, 8 mL D-0490-2026 Class III Premier Dental Products Co 2026-04-29

Source & provenance

Official source
https://open.fda.gov/apis/drug/enforcement/
Source dataset
openFDA Drug Enforcement API
Publication date
Not available
Ingested
2026-08-22

Verify every value against the official FDA source above. This site links to the regulator's record rather than replacing it.

Frequently asked questions

What is an FDA drug recall?

A drug recall is a regulatory action in which a firm removes or corrects a marketed product in cooperation with the FDA. The FDA records the action in its enforcement reports. A recall is an administrative action, not a clinical instruction to any individual.

What do Class I, Class II and Class III mean?

They are the FDA's regulatory severity tiers for a recall event. Class I denotes the most serious regulatory category, Class II an intermediate category, and Class III the least serious. These are administrative classifications of the recall event, not personalised risk statements.

Why do several recall pages share one event ID?

The FDA assigns one event ID per enforcement action and one recall number per recalled product configuration, so a single action covering three strengths of a product appears as three recall numbers under one event. This site keeps one page per recall number — that is the identifier the enforcement report is keyed on — and links every record under the same event to the others. 31 of the 118 indexed events cover more than one recall number.

Where does this recall data come from?

From the openFDA Drug Enforcement API, which exposes the FDA's enforcement reports in machine-readable form. Each record on this site links back to a verifiable openFDA query for the original report.

Does a recall mean a product is dangerous to me?

No. A recall record is an administrative fact about a regulatory action. It does not assess risk for any individual and is not medical advice. For any health question, consult a qualified healthcare professional and verify the record against the official FDA source.